Mayo Clinic researchers use milk-derived nanoparticles to target aggressive bile duct cancer
March 16, 2026
March 16, 2026
ROCHESTER, Minnesota, March 16 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Mayo Clinic researchers use milk-derived nanoparticles to target aggressive bile duct cancer
*
ROCHESTER, Minn. - Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors, a rare and aggressive bile duct cancer with limited treatment options, using milk-derived nanopartic . . .
* * *
Mayo Clinic researchers use milk-derived nanoparticles to target aggressive bile duct cancer
*
ROCHESTER, Minn. - Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors, a rare and aggressive bile duct cancer with limited treatment options, using milk-derived nanopartic . . .